• Users Online: 56
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
REVIEWS
A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferase
Peter Y. M. Woo, Yi Li, Anna H. Y. Chan, Stephanie C. P. Ng, Herbert H. F. Loong, Danny T. M. Chan, George K. C. Wong, Wai-Sang Poon
April-June 2019, 2(2):68-82
DOI:10.4103/glioma.glioma_3_19  
  11 7,171 911
Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas
Yang Xu, Fan-En Yuan, Qian-Xue Chen, Bao-Hui Liu
March-April 2018, 1(2):35-42
DOI:10.4103/glioma.glioma_10_17  
  7 5,203 653
ORIGINAL ARTICLES
BRAF mutation marks out specific subgroups of glioma
Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng
September-October 2018, 1(5):168-174
DOI:10.4103/glioma.glioma_33_18  
  5 4,653 516
REVIEWS
Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers
Francesca Gianno, Manila Antonelli, Elisabetta Ferretti, Maura Massimino, Antonietta Arcella, Felice Giangaspero
July-August 2018, 1(4):117-124
DOI:10.4103/glioma.glioma_27_18  
  5 9,215 1,145
ORIGINAL ARTICLES
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma
Steven Lehrer, Peter H Rheinstein, Kenneth E Rosenzweig
July-August 2018, 1(4):132-135
DOI:10.4103/glioma.glioma_17_18  
  4 2,996 366
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
Pingde Zhang, Ning Li, Karrie Mei Yee Kiang, Zhiyuan Zhu, Gloria Wai Man Leung, Stephen Yin Cheng, Gilberto Ka Kit Leung
September-October 2018, 1(5):175-181
DOI:10.4103/glioma.glioma_37_18  
  4 3,418 349
YKL-40 in high-grade glioma: Prognostic value of protein versus mRNA expression
Yu-Hang Zhao, Zhi-Yong Pan, Ze-Fen Wang, Chao Ma, Hong Weng, Zhi-Qiang Li
May-June 2018, 1(3):104-110
DOI:10.4103/glioma.glioma_16_18  
  4 3,233 337
REVIEWS
Histological approach to neuronal and mixed neuronal-glial tumors of the central nervous system
Char Loo Tan, Roger E McLendon
May-June 2018, 1(3):89-96
DOI:10.4103/glioma.glioma_24_18  
  4 6,951 898
Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
Maria Caffo, Salvatore Massimo Cardali, Elena Fazzari, Valeria Barresi, Gerardo Caruso
November-December 2018, 1(6):183-188
DOI:10.4103/glioma.glioma_43_18  
  4 3,805 423
ORIGINAL ARTICLES
Vasculogenic mimicry persists during glioblastoma xenograft growth
Cong Li, Yin-Sheng Chen, Qing-Ping Zhang, Jian-Liang Chen, Jing Wang, Fu-Rong Chen, Ho-Keung N G, Zhong-Ping Chen
January-February 2018, 1(1):16-21
DOI:10.4103/glioma.glioma_4_17  
  3 3,832 407
REVIEWS
Myeloid-derived suppressor cells and nonresolving inflammatory cells in glioma microenvironment: molecular mechanisms and therapeutic strategies
Xiao-Yan Ji, Jia-Wei Ma, Jun Dong
January-February 2018, 1(1):2-8
DOI:10.4103/glioma.glioma_2_17  
  3 3,556 412
ORIGINAL ARTICLES
Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
Matthieu Dreyfus, Michèle El-Atifi, Magali Court, Marie Bidart, Charles Coutton, Céline Leclech, Bruno Ballester, Emmanuel Garcion, Ali Bouamrani, François Berger, Didier Wion
March-April 2018, 1(2):66-78
DOI:10.4103/glioma.glioma_3_18  
  2 4,067 412
Evidence of calcium-activated potassium channel subunit alpha-1 as a key promoter of glioma growth and tumorigenicity
Divya Khaitan, Nagendra Ningaraj
January-March 2019, 2(1):46-54
DOI:10.4103/glioma.glioma_44_18  
  2 2,588 206
Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report
Chengcheng Guo, Qunying Yang, Jiawei Li, Shaoxiong Wu, Meiling Deng, Xiaojing Du, Ke Sai, Xiaobing Jiang, Zhenghe Chen, Ji Zhang, Fuhua Lin, Jian Wang, Yinsheng Chen, Chao Ke, Xiangheng Zhang, Xue Ju, Yonggao Mou, Jeffrey Bacha, Anne Steino, Sarath Kanekal, Claire Kwan, Gregory Johnson, Richard Schwartz, John Langlands, Dennis Brown, Zhong-ping Chen
October-December 2019, 2(4):167-173
DOI:10.4103/glioma.glioma_25_19  
  2 3,546 264
REVIEWS
Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma
Kunal Desai, Anne Hubben, Manmeet Ahluwalia
January-March 2019, 2(1):7-19
DOI:10.4103/glioma.glioma_5_19  
  2 5,651 460
Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
Xiaoran Zhang, Aleksandra Safonova, Aparna Rao, Nduka Amankulor
July-September 2019, 2(3):133-138
DOI:10.4103/glioma.glioma_10_19  
  2 3,579 351
Ongoing evolution of response assessment in glioma: Where do we stand?
Li Yi, Haolang Ming, Shengping Yu, Bingcheng Ren, Xuejun Yang
May-June 2018, 1(3):97-103
DOI:10.4103/glioma.glioma_13_18  
  2 4,264 478
The advances in targeted therapy and immunotherapy for glioblastoma: Basic research and clinical trials
Mei Wang, Xiaochun Jiang, Fubing Wu, Haojun Xu, Zihong Lin, Bin Qi, Hongping Xia
May-June 2018, 1(3):79-88
DOI:10.4103/glioma.glioma_10_18  
  2 5,917 704
CASE REPORT
Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
Sadhana Tiwari, Ishita Pant, Sujata Chaturvedi, Gurbachan Singh
January-March 2019, 2(1):55-59
DOI:10.4103/glioma.glioma_1_19  
  1 3,629 268
EDITORIAL
Glioma special issue introduction
Christopher Jackson, Michael Lim
January-March 2019, 2(1):1-2
DOI:10.4103/glioma.glioma_2_19  
  1 2,837 295
ORIGINAL ARTICLES
O-6-methylguanine-DNA methyltransferase promoter methylation can change in glioblastoma recurrence due to intratumor heterogeneity
Valeria Barresi, Maria Caffo, Giuseppa De Luca, Giuseppe Giuffrè
November-December 2018, 1(6):208-213
DOI:10.4103/glioma.glioma_38_18  
  1 2,753 287
IDH1 mutation decreases the invasiveness of glioma by downregulating the expression and activity of TAZ
Ningning Li, Rui Zhang, Yi Sun, Chenyue Xu, Yin Wang, Ji Xiong, Qi Chen, Ying Liu
January-March 2019, 2(1):37-45
DOI:10.4103/glioma.glioma_46_18  
  1 2,621 220
Real-world management and survival outcomes of patients with newly diagnosed gliomas from a single institution in China: A retrospective cohort study
Depei Li, Yinsheng Chen, Chengcheng Guo, Xiangheng Zhang, Ke Sai, Chao Ke, Ji Zhang, Xiaobing Jiang, Zhenghe Chen, Fuhua Lin, Qunying Yang, Jian Wang, Yonggao Mu, Zhongping Chen
April-June 2019, 2(2):96-104
DOI:10.4103/glioma.glioma_14_19  
  1 2,586 196
REVIEWS
Gamma-delta T cells in glioblastoma immunotherapy
Sadhak Sengupta
January-March 2019, 2(1):30-36
DOI:10.4103/glioma.glioma_48_18  
  1 6,576 674
Intraoperative fluorescence-guided resection of high-grade glioma: A systematic review
Lin Yang, Yan Xiang, Guo-Hao Huang, Hong-Yao Lyu, Ke-Jie Mou, Sheng-Qing Lv
November-December 2018, 1(6):189-195
DOI:10.4103/glioma.glioma_41_18  
  1 3,123 331
* Source: CrossRef